NCT05901597

Refractive Accuracy of Argos in Conjunction With the Alcon Vision Suite Following Implantation of Presbyopia Correcting IOLs

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 106 (actual)
• Sponsor: Valley Laser Eye Centre · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

The objective is to assess refractive accuracy of the Alcon Vision Suite (with Argos biometer) following Clareon PanOptix and AcrySof Vivity IOL implantation.

Detailed description

This study is a single-arm, observational study of refractive accuracy of the Alcon Vision Suite (with Argos biometer) following Clareon PanOptix and AcrySof Vivity IOL implantation. Subjects will be assessed at preoperatively, operatively, and 10 weeks post-operatively. Clinical evaluations will include measurement of monocular and binocular visual acuity, manifest refraction, and questionnaires will also be administered.

Conditions

• Cataract

Interventions

Type	Name	Description
DEVICE	Clareon PanOptix and AcrySof Vivity IOL implantation Alcon Vision Suite and Argos biometer	Clareon PanOptix and AcrySof Vivity IOL implantation Alcon Vision Suite and Argos biometer

Timeline

• Start date: 2023-05-09
• Primary completion: 2025-12-02
• Completion: 2025-12-02
• First posted: 2023-06-13
• Last updated: 2026-02-13

Locations

1 site across 1 country: Canada

Regulatory

• FDA-regulated device study